Template For Oral History Abstract Documents: Fill & Download for Free

Obesity is often seen as the main contributor to an increasing prevalence of diabetes [8–10] but other factors such as ageing, ethnicity, lifestyle (i.e., physical inactivity and energy dense diet), socioeconomic status, education, and urbanization have also been identified as potentially important factors [11–14].Diabetology & Metabolic SyndromeOpen AccessPublished: 09 November 2016Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysisVéronique Thibault, Mathieu Bélanger, […]Michelina MancusoDiabetology & Metabolic Syndrome volume 8, Article number: 71 (2016) Cite this article15k Accesses16 Citations7 AltmetricMetricsdetailsAbstractBackgroundThe prevalence of diabetes has increased since the last decade in New Brunswick. Identifying factors contributing to the increase in diabetes prevalence will help inform an action plan to manage the condition. The objective was to describe factors that could explain the increasing prevalence of type 2 diabetes in New Brunswick since 2001.MethodsA critical literature review was conducted to identify factors potentially responsible for an increase in prevalence of diabetes. Data from various sources were obtained to draw a repeated cross-sectional (2001–2014) description of these factors concurrently with changes in the prevalence of type 2 diabetes in New Brunswick. Linear regressions, Poisson regressions and Cochran Armitage analysis were used to describe relationships between these factors and time.ResultsFactors identified in the review were summarized in five categories: individual-level risk factors, environmental risk factors, evolution of the disease, detection effect and global changes. The prevalence of type 2 diabetes has increased by 120% between 2001 and 2014. The prevalence of obesity, hypertension, prediabetes, alcohol consumption, immigration and urbanization increased during the study period and the consumption of fruits and vegetables decreased which could represent potential factors of the increasing prevalence of type 2 diabetes. Physical activity, smoking, socioeconomic status and education did not present trends that could explain the increasing prevalence of type 2 diabetes. During the study period, the mortality rate and the conversion rate from prediabetes to diabetes decreased and the incidence rate increased. Suggestion of a detection effect was also present as the number of people tested increased while the HbA1c and the age at detection decreased. Period and birth cohort effect were also noted through a rise in the prevalence of type 2 diabetes across all age groups, but greater increases were observed among the younger cohorts.ConclusionsThis study presents a comprehensive overview of factors potentially responsible for population level changes in prevalence of type 2 diabetes. Recent increases in type 2 diabetes in New Brunswick may be attributable to a combination of some individual-level and environmental risk factors, the detection effect, the evolution of the disease and global changes.BackgroundWith 382 million people living with diabetes in 2013 [1], the World Health Organization declared the condition as being epidemic [2]. It is estimated that diabetes will affect 3.7 million Canadians in 2018, making it the principal health challenge of the country [3]. Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized [3]. Annual per capita healthcare costs for people with diabetes are three to four times greater than for individuals without diabetes [3]. New Brunswick is one of the provinces in Canada where the prevalence of diabetes is the highest [3]. The prevalence of diabetes is estimated to have increased by 86% in this province between 2000 and 2010 [4].A population-level increase in prevalence of diabetes may be attributable to a wide range of potential factors [5–7]. Obesity is often seen as the main contributor to an increasing prevalence of diabetes [8–10] but other factors such as ageing, ethnicity, lifestyle (i.e., physical inactivity and energy dense diet), socioeconomic status, education, and urbanization have also been identified as potentially important factors [11–14]. Further findings also suggest that increasing incidence rates of diabetes [15–18] and global changes are other potential explanatory factors (e.g. environmental pollution, obesogenic environment and rapid socioeconomic development) that could affect the entire population [19, 20]. In addition to changes in the prevalence of risk factors, other elements, including increases in screening [10], changes in diagnostic criteria [21], and decreasing mortality rates among individuals with diabetes [15–18, 22–32] could contribute to the rise in prevalence of this condition.Perhaps due to the wide variety of factors potentially responsible for an increase in prevalence of diabetes, no studies have attempted to present a comprehensive list of factors which could be responsible for population-level changes in prevalence of diabetes. A comprehensive list of factors that contribute to the growing prevalence of diabetes would provide a foundation for population health planning in developing successful strategies to address this epidemic of diabetes. As such, the objectives of this study were (1) to develop a comprehensive list of factors to consider when trying to identify causes of change in prevalence of diabetes in a population and (2) to use this list to describe factors that may be responsible for the recent increase in prevalence of type 2 diabetes in New Brunswick.MethodsStep 1: critical review procedureA critical review of the literature was conducted to identify all factors potentially involved in explaining changes in the prevalence of diabetes. A critical review includes an extensive research of the literature and an evaluation of its quality without a systematic research approach [33]. This type of review includes a description of identified articles, synthesizes and analyzes the information to develop an hypothesis or a model for further study [33]. The first step of the critical review was to identify studies that aimed to document a wide range of factors explaining changes in the prevalence of diabetes. The following term was used in the PubMed database to identify only review articles: “Review[ptyp]”. Additional terms were also entered at this step to identify any review articles on the topic of diabetes prevalence, trends, or epidemiology: “prevalence” [title/abstract] AND “diabetes/prevention and control “[majr] OR (“Diabetes” [title/abstract] AND “trends” [title/abstract] OR “diabetes/epidemiology “[majr]). The second step of the critical review searched studies that described other factors without restricting to only review articles. At this point, we used this research procedure “prevalence” [title/abstract] AND (“diabetes/prevention and control “[majr]) OR (“Diabetes” [title/abstract] AND “trends” [title/abstract]). From the 3215 articles of the first research procedure and 1907 of the second, 446 were duplicates. Of the 4676 unique articles, we retained six review articles that presented multiple potential determinants of diabetes prevalence. All other articles were scanned to retain any articles (n = 71) which presented other factors not considered in the review articles identified and to provide additional empirical support to the factors identified in the reviews. In total, 77 articles were included in this critical review.Step 2: description of potential determinants of diabetes prevalenceData sources and study populationThe changes in factors potentially involved in explaining an increase in a population’s prevalence of diabetes identified in the critical review were studied using a descriptive repeated cross sectional analysis approach. De-identified registries of all individuals with diabetes and all individuals with prediabetes were created from New Brunswick Department of Health administrative datasets and were stored in a secured office within the New Brunswick Health Council. Those administrative datasets included the list of all New Brunswickers with provincial healthcare coverage (all Canadian residing in New Brunswick) and a repository of all HbA1c tests conducted between 2001 and 2014. Individuals were identified as having diabetes the first time they had a HbA1c test ≥6.5% (48 mmol/mol) and were excluded from prevalence estimates after they died based on their date of death. Similarly, individuals were identified as having prediabetes the first time they had a HbA1c test between 6.0 (42 mmol/mol) and 6.4% (47 mmol/mol) and were removed from the prediabetes registry if they developed diabetes, or if they had a normal HbA1c test (<6.0%) (<42 mmol/mol), or if they died. Because only type 2 diabetes population was of interest for this study and because it was not possible to differentiate the type of diabetes in the diabetes registry, only those ≥30 years of age at detection were included in the analysis, with no maximum age limit. This approach is used by the New Brunswick Department of Health for their provincial reports and has been used by other authors [6] since diabetes cases diagnosed before this age are more often type 1 diabetes [34]. Other data were obtained from the Canadian Census of Population, the Canadian Community Health Survey, the National Household Survey, the Labour Force Survey and the Income Statistics Division from Statistics Canada. The New Brunswick databases used for this study were completely anonymized and the study was approved by the Institutional Review Board of the Centre hospitalier universitaire de l’Université de Sherbrooke.VariablesPrevalence of diabetes and prediabetes were measured annually as the proportion of individuals with diabetes and the proportion of individuals with prediabetes divided by their respective populations at risk during the fiscal year, defined as April 1st to March 31st. The population at risk was determined based on the number of New Brunswickers aged 30 or older recorded from the annual estimates of the population from Statistics Canada. The denominator for incidence rates corresponded to the at-risk population described above minus the prevalent cases and incident cases during the year. Mortality rate corresponded to the number of people with diabetes who died during the fiscal year. The denominator included all people living with diabetes, including the time alive among those who died within the given year. The conversion rate from prediabetes to diabetes was calculated as the number of individuals with prediabetes who developed diabetes during the fiscal year over the number of individuals with prediabetes. Number of people with HbA1c testing was defined annually as the number of people with at least one HbA1c test during the fiscal year. Age at detection was derived from the date at which the first test attained the diagnostic threshold and the documented birth date of the individuals. HbA1c at detection was obtained by averaging the HbA1c value at detection of all incident cases for each fiscal year. The breakdown of the population by age groups was obtained from 2001 to 2014 from annual estimates of the entire New Brunswick population from Statistics Canada. The prevalence of select risk factors was determined from self-reported information available for the New Brunswick population from the Canadian Community Health Survey in 2003, 2005 and annually from 2007 to 2014 for people aged 35 years old and greater. These risk factors included obesity (body mass index ≥30, calculated from self-reported height and weight data), hypertension (self-reported diagnosis received from a healthcare professional), consumption of fruits and vegetables (eating fruits and vegetables usually more than five times per day), physical activity (categorized as active or inactive based on the average daily physical activity reported for the 3 previous months), alcohol consumption (having drunk more than five glasses of alcohol at one occasion, at least once a month during the last year—note that because of changes in definitions in 2013, only data up to 2012 were considered herein) and smoking (smoking cigarettes every day). Level of education (number of people who completed high school; number with a university degree) was obtained from the Labour Force Survey from 2001 to 2014. Socioeconomic status (percentage of people having low income before taxes) was available from 2001 to 2011 from the Income Statistics Division of Statistics Canada and urbanization (people living in a rural area, defined as any territory situated outside population centers which contain a population of at least 1000 person and a density of 400 or more person by square kilometer) was obtained from Census data for 2001, 2006 and 2011. Ethnicity (percentage of immigration used as a proxy for ethnicity herein) was also obtained from Census data for 2001 and 2006 and from the National Household Survey for 2011.Statistical analysisCochran–armitage analyses of trend were used to assess the association between time (fiscal year) and variables represented as yearly prevalence. Poisson regressions were used to assess associations between time and mortality rate and between time and conversion rate from prediabetes to diabetes. Linear regressions were used to assess time trends in number of people who undergone HbA1c testing, the average value of HbA1c and the average age at detection. Assessing the presence of a period effect was done by calculating the prevalence of diabetes across 10 year age groups (30–39, …, 90+) for each fiscal year. Assessing for the presence of a birth cohort effect was also done by calculating the prevalence of diabetes among decade-of-birth-based cohorts (1910–1920, …, 1961–1970) for each fiscal year.ResultsFrom 101,519 individuals identified with diabetes in the registry between 2001 and 2014, 97,865 individuals were included because they were diagnosed at 30 years old or older. The prevalence of type 2 diabetes increased by an average of 6.4% per year over this time period, which represents an overall increase of 120% (Table 1). The critical literature review identified several factors that could potentially explain such a change in the prevalence of diabetes at a population level. The factors have been grouped in five categories (Table 2) which are defined below. A description of these factors from 2001 to 2014 in New Brunswick is also presented to better understand how they could have contributed to the rise in prevalence of diabetes in this region. In Table 2, factors for which we found information and which we included in the analyses are presented in italics.Table 1 Description of factors related to the prevalence of type 2 diabetesFull size tableTable 2 Factors potentially involved in explaining changes in a population’s prevalence of diabetesFull size tableIndividual-level risk factorsAccording to the literature review, the rise in a population’s prevalence of diabetes could be attributed to increases in that population’s prevalence of individual-level risk factors for the condition. Concurrently, we noted a marked increase in the prevalence of prediabetes from 2001 to 2014 (Table 1). Increases were also noted in the prevalence of obesity, hypertension, alcohol consumption, and immigration over the same period of time. During the study period, we also found the population was aging and that the prevalence of consumption of fruits and vegetables decreased.However, the proportion of people reporting a physically active lifestyle, sedentary behaviours, tobacco smoking, having completed high school and university education, and being of low income evolved in directions that were opposite to the direction expected to be considered as a factor contributing to the increasing prevalence of diabetes.Environmental risk factorsThe literature review has shown that some environmental risk factors such as the presence of environmental pollutants (such as nitrogen dioxide (NO2), particulate matter (PM), organic persistent pollutants and non-persistent pesticides), urbanization and rapid socioeconomic development could explain part of the increase in the prevalence of diabetes. In this study, the only factor that was possible to measure was the urbanization based on the proportion of people living in a rural area. This proportion decreased during the study period and evolved in a direction supporting that it may have influenced the increase in prevalence of diabetes in New Brunswick (Table 1).Evolution of the diseaseSome factors characterizing the evolution of the disease, including survival time among individuals with diabetes, number of new cases of diabetes and conversion to diabetes from prediabetes population, could explain the increase in the prevalence of diabetes. In this study, we found that only two of these factors evolved in the direction expected if these factors were to explain the increase in prevalence of diabetes. The incidence rate increased from 2001 to 2014 and a higher increase in the incidence rate was seen around 2002 and 2005 (Table 1). The mortality rate of the population with diabetes decreased in the same period. In contrast, the conversion rate from prediabetes to diabetes could not explain the increase in prevalence of diabetes because it decreased during this period.Detection effectThe literature review also suggested that a change in prevalence of disease could be attributed to changes in how the condition is identified. The detection effect could be related to an increase in the number of people being screened or diagnosed, an earlier detection of the disease and changes in diagnostic criteria. Accordingly we found that the number of people tested for HbA1c increased from 2001 to 2014 and showed a higher increase around 2003 and 2010 (Fig. 1). Concurrently, the mean HbA1c at detection decreased between 2001 and 2014 suggesting that people are being diagnosed earlier in the evolution of the disease (Table 1). It was also noted that the percentage of individuals with diabetes previously identified with prediabetes increased from 2001 to 2014, also suggesting that people are being detected at an earlier stage of their disease. The average age at detection also supports the presence of a detection effect since data suggest that people are being diagnosed at a younger age.Fig. 1figure1Number of individuals who received at least one HbA1c test by fiscal yearFull size imageGlobal changesChanges in any or a combination of factors above may affect all of the population regardless of people’s age (period effect). Changes in factors could also be more pronounced in segments of the population, based on the year of birth (birth cohort effect). In this study, the presence of a period effect was supported by an increase in the prevalence of type 2 diabetes from 2001 and 2014 in each age group, with the 40–49 year old age group displaying a greater increase (Fig. 2a). The presence of a birth cohort effect was also suggested since the increase in prevalence of type 2 diabetes was considerably greater among the youngest birth cohort compared to the oldest birth cohorts (Fig. 2b).Fig. 2figure2a Relative percentage of change in prevalence of type 2 diabetes by age groups (2001–2014). b Relative percentage of change in prevalence of type 2 diabetes by birth cohort group (2001–2014)Full size imageDiscussionThe prevalence of type 2 diabetes has more than doubled in the past 15 years in New Brunswick. Although this prevalence change is relatively greater than changes noted elsewhere, this is consistent with the increase in prevalence in diabetes observed in recent years in other provinces and countries around the world [69, 72]. To help identify factors responsible for this increase, our literature review led to the identification of five categories of factors which together represent a comprehensive overview of factors that could explain a change in prevalence of diabetes. Our review included considerably more potential factors than what had been reported in other literature reviews [5–7, 35, 57, 73]. Guided by this inventory, we assessed the changes in nearly all factors suggested to potentially influence the prevalence of diabetes in New Brunswick. Through this work, we identified that changes in prevalence of diabetes in New Brunswick are likely attributed to a combination of numerous factors.Among individual-level risk factors identified in the critical review, our analysis suggests that the presence of other conditions, such as the aging population, obesity, hypertension and prediabetes could contribute to explain the increase in prevalence of type 2 diabetes in New Brunswick. Furthermore, although immigration increased in NB, it is difficult to conclude that ethnicity might have an effect on the prevalence of type 2 diabetes in NB since no information is available on ethnic origin of immigrants in the databases used.An increase in prevalence of obesity or body mass index has been linked to increases in the prevalence of diabetes in many other studies [8, 37–39, 68] and authors suggested it is the most important contributor to increases in prevalence of diabetes [8–10]. Consistent with changes in body composition of the population, we also noted that diet quality decreased over the study period. However, our data suggest that New Brunswickers became more physically active in the past 15 years, which does not concord with trends for obesity and diabetes. It has been suggested that this discrepancy may be attributable to measurement error associated with the use of self-reported measures [74]. Self-reported measures, such as physical activity levels, are suspected to have been influenced by an increase in social desirability possibly creating higher estimates over the years [74]. However, our results are consistent with the apparent increase in prevalence of a physically active lifestyle in the United States from 2001 and 2009, which seems to have had minimal impact on reducing the burden of obesity [75]. Among the potential for environmental risk factors to have influenced diabetes, we only had access to data relating to urbanization and these suggested that the transition from a predominantly rural to an urban population accompanied the increase in prevalence of diabetes in New Brunswick. This transition may mean that a greater proportion of the population may be exposed to obesogenic environments such as more sedentary work, higher use of car and public transport, television viewing and in short, lower levels of physical activity [6]. Although environmental pollution can be present in rural regions, it is also possible that urbanization has led to more exposure to pollutants. A meta-analysis has shown that the prolonged exposition to nitrogen dioxide (NO2), particulate matter less than 2.5 mm (PM2.5), and particulate matter less than 10 micrometers (PM10) was associated to type 2 diabetes incidence in cohort studies [55].Changes in how diabetes evolves may also contribute to explaining a change in how the prevalence of disease increased in New Brunswick. Most particularly, we noted a decline in mortality rates of people with diabetes from 2001 to 2014, which is consistent with results from other studies [18, 22, 23, 26–28, 31]. The 40% decrease in mortality rates observed in our study over 14 years is similar to the 37.2% decrease in mortality witnessed in Ontario between 1996 and 2009 [29]. A longer survival period in the population with diabetes, likely explained by better treatment and control of the disease [48], therefore contributed to the increase in prevalence. An increase in the conversion rate from prediabetes to diabetes could also have explained an increase in diabetes prevalence [65]. However, this study shows a decrease in the conversion rate from prediabetes to diabetes, therefore suggesting either better prevention efforts in this population at risk or a relatively higher proportion of people identified with prediabetes through more screening.As our data indicated, it is highly probable that part of the increase in prevalence of diabetes can be attributed to a detection effect whereby the number of people tested with HbA1c rose markedly during the study period. Although the increase in testing was observed every year, sharper increases appeared to coincide with milestones such as the publication of the 2003 and 2008 guidelines encouraging type 2 diabetes screening [76, 77] and the identification of HbA1c as a recognised diagnostic tool by the American Diabetes Association in 2010 [78]. The possibility of earlier detection of the disease is also supported by a decrease in HbA1c levels and age at detection during the study period. The increase in testing and an early detection may also partly be explained by the study period corresponding with the introduction of financial incentives for physicians to offer recommended care to their patients with diabetes (2010), the implementation of an HbA1c tracking tool created to improve adherence to guidelines (2009) [79] and the Physician Practice profiles implemented in 2010 to aid physicians to identify at risk patients in New Brunswick. It should also be mentioned that although our analysis did not allow for the assessment of the relative contribution of each factor, another study suggested that improvements in detection of diabetes could explain as much as 25% of the increase in the prevalence of diabetes diagnosed since 1970 [10].The fact that an increase in the prevalence of type 2 diabetes was observed in all age groups over the 15 years of study supports the presence of a period effect. The percentage of change in the prevalence of diabetes was nevertheless higher among the 40–49 years old, as it is possible that this group benefited from a higher detection effect than other age groups. The period effect could be attributed to a combination of any of the other factors identified in this study, including urbanization, increases in immigration and an increase in the detection. Other factors not measured, such as rapid socioeconomic development and increase in environmental pollution, could also be at play [19]. The data also presented evidence of a birth cohort effect as we observed higher increases in the prevalence of type 2 diabetes in the younger cohort groups. This could be explained by exposure early in life to some environmental factors related to an increase in obesity, as suggested by Soon et al. [19]. These results are consistent with others who demonstrated that steeper increases in the prevalence of diabetes in the youngest cohort parallel increases in the prevalence of obesity in the younger generations [19, 20]. The development of more obesogenic environment may affect younger people to a greater extent than other age groups since it represents a great proportion of their relative environmental exposure [19]. Further, another study reported that weight gain between 25 and 40 years old was associated with a higher risk of diabetes than a weight gain after 40 years old [80].The present study has some limitations that need to be acknowledged. First, because of the descriptive design of the study, it was not possible to quantify and contrast the relative contribution of each factor. Second, the prevalence of diabetes and prediabetes could be underestimated due to the use of only one diagnostic method (HbA1c test) in determining presence of disease and because HbA1c was only endorsed as a diagnostic method after 2010. However, because the HbA1c test had been in significant use prior to 2010 for the management of the disease [81], we hypothesise that most of the time a diagnosis of diabetes was followed by a HbA1c test a short period after. In the same way, the detection effect measured in part by the number of people tested with a HbA1c could be overestimated by the fact that the HbA1c values for prediabetes or diabetes screening had not been identified before 2010 and we did not consider other screening tests such as fasting glucose and oral glucose tolerance test which were often used before 2010. However, HbA1c test has different sensitivity, specificity and utility than other diagnostic tests such as OGTT and fasting glucose [35] and because of that, it is advisable to use the same diagnostic test over time. Also, even though the HbA1c test is not universally accepted as a diagnostic tool [82] and may be affected by some individual conditions [83], it represents less individual variability than other tests and provides a better reflection of the glucose homeostasis in the long term [84]. Third, because it was not possible to distinguish the type of diabetes in the diabetes registry, it was not possible to exclude gestational diabetes cases and type 1 diabetes was excluded only on the basis of age. However, the 4% exclusion of potential type 1 diabetes individuals is close to the proportion of type 1 diabetes which is estimated to represent about 5-10% of cases of diabetes [85]. Fourth, it was not possible to measure some risk factors because of lack of data available, including gestational diabetes, intra uterin environnment, nutritional transition status, family diabetes history, environmental pollution, rapid socioeconomic development and high triglycerides. Fifth, our description of risk factors was performed concurrently to the change in prevalence of diabetes we were attempting to explain. Since diabetes has a long latency period, it may be appropriate to start describing those factors before 2001. This study also has strengths that need to be highlighted. This is the first study that describes an overview of factors that could explain the increase in prevalence of type 2 diabetes and used a population based analysis to measure almost all of those factors. The majority of analysis was done on the entire New Brunswick population and almost all the data was available for the 15 year period.ConclusionsIn conclusion, this study presents a comprehensive overview of potential factors that could explain the change in the prevalence of type 2 diabetes. This study shows that for the past 15 years, the prevalence of diabetes in New Brunswick has increased considerably and this increase could be explained by many factors including some individual-level and environmental risk factors, the detection effect, the evolution of the disease and global changes. However, the increasing prevalence of diabetes observed may not be as impressive as it appears due to the significant influence of the detection effect and the dramatic decrease in mortality. A better understanding of factors potentially responsible for the increase in type 2 diabetes can assist in making informed decisions about diabetes programs and policies. This study may be used as a template for other countries or provinces to identify factors that could explain the increase in the prevalence of diabetes in their respective jurisdictions. More research is needed to measure the relative contribution of each factor on the increase in prevalence of diabetes by measuring each factor directly at the individual level and to evaluate the change in risk factors earlier in the evolution of the disease.References1.International diabetes federation. Diabetes Atlas 6th edition. 2013 http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf. Accessed 15 May 2016.2.World Health Organisation. Diabetes. 2016. Diabetes. Accessed 15 May 2016.3.Public Health Agency Diabetes in Canada: facts and figures from a public health perspective. 2011. Diabetes in Canada: Facts and figures from a public health perspective. Accessed 15 May 2016.4.Canadian diabetes association. The cost of diabetes in New Brunswick. 2009.5.Li H, Oldenburg B, Chamberlain C, et al. Diabetes prevalence and determinants in adults in China mainland from 2000 to 2010: a systematic review. Diabetes Res Clin Pract. 2012;98:226–35. doi:10.1016/j.diabres.2012.05.010.ArticlePubMedGoogle Scholar6.Hawley NL, McGarvey ST. Obesity and diabetes in Pacific Islanders: the current burden and the need for urgent action. Curr Diab Rep. 2015;15:29. doi:10.1007/s11892-015-0594-5.ArticlePubMedGoogle Scholar7.Bhattarai MD. Three patterns of rising type 2 diabetes prevalence in the world: need to widen the concept of prevention in individuals into control in the community. J Nepal Med Assoc. 2009;48:173–9.CASGoogle Scholar8.Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28:169–80. doi:10.1007/s10654-013-9771-5.ArticlePubMedPubMed CentralGoogle Scholar9.Zhang Q, Wang Y, Huang ES. Changes in racial/ethnic disparities in the prevalence of type 2 diabetes by obesity level among US adults. Ethn Health. 2009;14:439–57. doi:10.1080/13557850802699155.ArticlePubMedPubMed CentralGoogle Scholar10.Smith JP. Nature and causes of trends in male diabetes prevalence, undiagnosed diabetes, and the socioeconomic status health gradient. Proc Natl Acad Sci USA. 2007;104:13225–31. doi:10.1073/pnas.0611234104.CASArticlePubMedPubMed CentralGoogle Scholar11.Menke A, Rust KF, Fradkin J, et al. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States. Ann Intern Med. 2014;161:328. doi:10.7326/M14-0286.ArticlePubMedGoogle Scholar12.Oggioni C, Lara J, Wells JCK, et al. Shifts in population dietary patterns and physical inactivity as determinants of global trends in the prevalence of diabetes: an ecological analysis. Nutr Metab Cardiovasc Dis. 2014;24:1105–11. doi:10.1016/j.numecd.2014.05.005.CASArticlePubMedGoogle Scholar13.Saidi O, O’Flaherty M, Ben Mansour N, et al. Forecasting Tunisian type 2 diabetes prevalence to 2027: validation of a simple model. BMC Public Health. 2015;15:104. doi:10.1186/s12889-015-1416-z.ArticlePubMedPubMed CentralGoogle Scholar14.Jan Mohamed HJB, Yap RWK, Loy SL, et al. Prevalence and determinants of overweight, obesity, and type 2 diabetes mellitus in adults in Malaysia. Asia Pac J Public Heal. 2014;. doi:10.1177/1010539514562447.Google Scholar15.Gujral UP, Echouffo-Tcheugui JB, Narayan KMV. Commentary: trends in prevalence of type 2 diabetes and prediabetes in South Asians–does it tell a story? Int J Epidemiol. 2011;40:1554–5. doi:10.1093/ije/dyr195.ArticlePubMedGoogle Scholar16.Monesi L, Baviera M, Marzona I, et al. Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study. Diabet Med. 2012;29:385–92. doi:10.1111/j.1464-5491.2011.03446.x.CASArticlePubMedGoogle Scholar17.Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet. 2007;369:750–6. doi:10.1016/S0140-6736(07)60361-4.ArticlePubMedGoogle Scholar18.Evans JMM, Barnett KN, Ogston SA, Morris D. Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality. Diabetologia. 2007;50:729–32. doi:10.1007/s00125-006-0585-9.CASArticlePubMedGoogle Scholar19.Soon YE. Effects of age, time period, and birth cohort on the prevalence of diabetes and obesity in Korean men. Diabetes Care. 2008. doi:10.2337/dc07-0531.Google Scholar20.Fishman EI, Stokes A, Preston SH. The dynamics of diabetes among birth cohorts in the U.S. Diabetes Care. 2014;37:1052–9. doi:10.2337/dc13-1982.CASArticlePubMedPubMed CentralGoogle Scholar21.Takahashi Y, Noda M, Tsugane S, Kuzuya T, Ito CKT. Standardized Measurement of HbA1c. Diabetes Care. 2000;23:8.Google Scholar22.Karpati T, Cohen CJ, Leibowitz M. Is the diabetes epidemic subsiding? Trends from a large population-based observational study in Israel. Popul Health Metr. 2014;12:1–8. doi:10.1186/s12963-014-0032-y.ArticleGoogle Scholar23.Oster RT, Johnson JA, Hemmelgarn BR, et al. Recent epidemiologic trends of diabetes mellitus among status Aboriginal adults. CMAJ. 2011;183:E803–8. doi:10.1503/cmaj.101882.ArticlePubMedPubMed CentralGoogle Scholar24.Eliasson M, Talbäck M, Rosén M. Improved survival in both men and women with diabetes between 1980 and 2004–a cohort study in Sweden. Cardiovasc Diabetol. 2011;7:32. doi:10.1186/1475-2840-7-32.ArticleGoogle Scholar25.Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 2012;35:1252–7. doi:10.2337/dc11-1162.ArticlePubMedPubMed CentralGoogle Scholar26.Narayanan ML, Schraer CD, Bulkow LR, et al. Diabetes prevalence, incidence, complications and mortality among Alaska Native people 1985–2006. Int J Circumpolar Health. 2010;69:236–52. doi:10.3402/ijch.v69i3.17618.ArticlePubMedGoogle Scholar27.Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia. 2008;51:2187–96. doi:10.1007/s00125-008-1156-z.CASArticlePubMedGoogle Scholar28.Gulliford MC, Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol. 2009;169:455–61. doi:10.1093/aje/kwn342.ArticlePubMedGoogle Scholar29.Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013;56:2601–8. doi:10.1007/s00125-013-3063-1.CASArticlePubMedGoogle Scholar30.Green A, Sjølie AK, Eshøj O. Trends in the epidemiology of IDDM during 1970-2020 in Fyn County. Denmark. Diabetes Care. 1996;19:801–6.CASArticlePubMedGoogle Scholar31.Thomas RJ, Palumbo PJ, Melton LJ, et al. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med. 2003;163:445–51.ArticlePubMedGoogle Scholar32.Johnson JA, Balko SU, Hugel G. Increasing incidence and prevalence with limited survival gains among rural Albertans with diabetes: a retrospective cohort study, 1995–2006. Diabet Med. 2009;26:989–95. doi:10.1111/j.1464-5491.2009.02805.x.CASArticlePubMedGoogle Scholar33.Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26:91–108. doi:10.1111/j.1471-1842.2009.00848.x.ArticlePubMedGoogle Scholar34.Ozougwu O. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013;4:46–57. doi:10.5897/JPAP2013.0001.ArticleCASGoogle Scholar35.Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;. doi:10.1038/nrendo.2011.183.Google Scholar36.Ha KH, Kim DJ. Trends in the diabetes epidemic in Korea. Endocrinol Metab. 2015;30:142–6. doi:10.3803/EnM.2015.30.2.142.ArticleGoogle Scholar37.Bhowmik B, Afsana F, My Diep L, et al. Increasing prevalence of type 2 diabetes in a rural bangladeshi population: a population based study for 10 years. Diabetes Metab J. 2013;37:46–53. doi:10.4093/dmj.2013.37.1.46.ArticlePubMedPubMed CentralGoogle Scholar38.Chittleborough CR, Grant JF, Phillips PJ, Taylor AW. The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesity. Public Health. 2007;121:92–9. doi:10.1016/j.puhe.2006.09.017.CASArticlePubMedGoogle Scholar39.Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U. S.: 1990–1998. Diabetes Care. 2000;23(9):1278–83.CASArticlePubMedGoogle Scholar40.Garcia-Dominic O, Lengerich EJ, Camacho F, et al. Prevalence of diabetes and associated obesity in Pennsylvania adults, 1995–2010. Prev Chronic Dis. 2014;11:E111. doi:10.5888/pcd11.130330.ArticlePubMedPubMed CentralGoogle Scholar41.Holman N, Forouhi NG, Goyder E, Wild SH. The association of public health observatories (APHO) diabetes prevalence model: estimates of total diabetes prevalence for England, 2010–2030. Diabet Med. 2011;28:575–82. doi:10.1111/j.1464-5491.2010.03216.x.CASArticlePubMedGoogle Scholar42.Shih M, Du Y, Lightstone AS, et al. Stemming the tide: rising diabetes prevalence and ethnic subgroup variation among Asians in Los Angeles County. Prev Med (Baltim). 2014;63:90–5. doi:10.1016/j.ypmed.2014.03.016.ArticleGoogle Scholar43.Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA. 2014;312:1218–26. doi:10.1001/jama.2014.11494.CASArticlePubMedGoogle Scholar44.Zuo H, Shi Z, Hussain A. Prevalence, trends and risk factors for the diabetes epidemic in China: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2014;104:63–72. doi:10.1016/j.diabres.2014.01.002.ArticlePubMedGoogle Scholar45.Villalpando S, Shamah-Levy T, Rojas R, Aguilar-Salinas CA. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993–2006. Salud Publica Mex. 2010;52(Suppl 1):S72–9.PubMedGoogle Scholar46.Mainous AG, Tanner RJ, Baker R, et al. Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open. 2014;4:e005002. doi:10.1136/bmjopen-2014-005002.ArticlePubMedPubMed CentralGoogle Scholar47.Liu S, Manson JE, Stampfer MJ, et al. A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health. 2000;90:1409–15. doi:10.2105/AJPH.90.9.1409.CASArticlePubMedPubMed CentralGoogle Scholar48.Li M-Z, Su L, Liang B-Y, et al. Trends in prevalence, awareness, treatment, and control of diabetes mellitus in mainland china from 1979 to 2012. Int J Endocrinol. 2013;2013:753150. doi:10.1155/2013/753150.PubMedPubMed CentralGoogle Scholar49.Molsted S, Johnsen NF, Snorgaard O. Trends in leisure time physical activity, smoking, body mass index and alcohol consumption in Danish adults with and without diabetes: a repeat cross-sectional national survey covering the years 2000 to 2010. Diabetes Res Clin Pract. 2014;105:217–22. doi:10.1016/j.diabres.2014.05.009.ArticlePubMedGoogle Scholar50.Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790–7.CASArticlePubMedGoogle Scholar51.Lindahl B, Stenlund H, Norberg M. Increasing glucose concentrations and prevalence of diabetes mellitus in northern Sweden, 1990–2007. Glob Health Action. 2010;. doi:10.3402/gha.v3i0.5222.Google Scholar52.Espelt A, Kunst AE, Palència L, et al. Twenty years of socio-economic inequalities in type 2 diabetes mellitus prevalence in Spain, 1987–2006. Eur J Public Health. 2012;22:765–71. doi:10.1093/eurpub/ckr158.ArticlePubMedGoogle Scholar53.Jayawardena R, Ranasinghe P, Byrne NM, et al. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health. 2012;12:380. doi:10.1186/1471-2458-12-380.ArticlePubMedPubMed CentralGoogle Scholar54.Rao X, Montresor-Lopez J, Puett R, et al. Ambient air pollution: an emerging risk factor for diabetes mellitus. Curr Diab Rep. 2015;15:603. doi:10.1007/s11892-015-0603-8.ArticleCASPubMedGoogle Scholar55.Wang B, Xu D, Jing Z, et al. Effect of long-term exposure to air pollution on type 2 diabetes mellitus risk: a systemic review and meta-analysis of cohort studies. Eur J Endocrinol. 2014;171:R173–82. doi:10.1530/EJE-14-0365.CASArticlePubMedGoogle Scholar56.Jaacks LM, Staimez LR. Association of persistent organic pollutants and non-persistent pesticides with diabetes and diabetes-related health outcomes in Asia: a systematic review. Environ Int. 2015;76:57–70. doi:10.1016/j.envint.2014.12.001.CASArticlePubMedGoogle Scholar57.Colagiuri S, Borch-Johnsen K, Glümer C, Vistisen D. There really is an epidemic of type 2 diabetes. Diabetologia. 2005;48:1459–63. doi:10.1007/s00125-005-1843-y.CASArticlePubMedGoogle Scholar58.Geiss LS, Pan L, Cadwell B, et al. Changes in incidence of diabetes in U.S. adults, 1997–2003. Am J Prev Med. 2006;30:371–7. doi:10.1016/j.amepre.2005.12.009.ArticlePubMedGoogle Scholar59.Lin C-C, Li C-I, Hsiao C-Y, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013;13:318. doi:10.1186/1471-2458-13-318.ArticlePubMedPubMed CentralGoogle Scholar60.Oster RT, Johnson JA, Balko SU, et al. Increasing rates of diabetes amongst status Aboriginal youth in Alberta, Canada. Int J Circumpolar Health. 2012;71:1–7. doi:10.3402/ijch.v71i0.18501.ArticlePubMedGoogle Scholar61.Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the framingham heart study. Diabetes Care. 2015;38:482–7. doi:10.2337/dc14-1432.ArticlePubMedGoogle Scholar62.Tseng C-H, Tseng C-P, Chong C-K, et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia. 2006;49:1755–60. doi:10.1007/s00125-006-0314-4.ArticlePubMedGoogle Scholar63.Leibson C, Milton LJ, Palumbo PJ. Temporal trends in diabetes incidence and prevalence. Diabetes Care. 1997;20:460–2.CASArticlePubMedGoogle Scholar64.Li W, Wang Y, Chen L, et al. Increasing prevalence of diabetes in middle or low income residents in Louisiana from 2000 to 2009. Diabetes Res Clin Pract. 2011;94:262–8. doi:10.1016/j.diabres.2011.08.010.ArticlePubMedGoogle Scholar65.Söderberg S, Zimmet P, Tuomilehto J, et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med. 2004;256:37–47. doi:10.1111/j.1365-2796.2004.01336.x.ArticlePubMedGoogle Scholar66.Estoppey D, Paccaud F, Vollenweider P, Marques-Vidal P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997–2007. BMC Public Health. 2011;11:114. doi:10.1186/1471-2458-11-114.ArticlePubMedPubMed CentralGoogle Scholar67.Gregg EW, Cadwell BL, Cheng YJ, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care. 2004;27:2806–12. doi:10.2337/diacare.27.12.2806.ArticlePubMedGoogle Scholar68.Esteghamati A, Etemad K, Koohpayehzadeh J, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract. 2014;103:319–27. doi:10.1016/j.diabres.2013.12.034.ArticlePubMedGoogle Scholar69.Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014;160:517–25. doi:10.7326/M13-2411.ArticlePubMedPubMed CentralGoogle Scholar70.Koopman RJ, Mainous AG, Diaz VA, Geesey ME. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med. 2005;3:60–3. doi:10.1370/afm.214.ArticlePubMedPubMed CentralGoogle Scholar71.Fu J-F, Liang L, Gong C-X, et al. Status and trends of diabetes in Chinese children: analysis of data from 14 medical centers. World J Pediatr. 2013;9:127–34. doi:10.1007/s12519-013-0414-4.ArticlePubMedGoogle Scholar72.Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40. doi:10.1016/S0140-6736(11)60679-X.CASArticlePubMedGoogle Scholar73.Jan Mohamed HJB, Yap RWK, Loy SL, et al. Prevalence and determinants of overweight, obesity, and type 2 diabetes mellitus in adults in Malaysia. Asia Pac J Public Health. 2015;27:123–35. doi:10.1177/1010539514562447.ArticlePubMedGoogle Scholar74.Tremblay M. The need for directly measured health data in Canada. Can J Public Health. 2004;95:165–8.PubMedGoogle Scholar75.Dwyer-Lindgren L, Freedman G, Engell RE, et al. Prevalence of physical activity and obesity in US counties, 2001–2011: a road map for action. Popul Health Metr. 2013;11:7. doi:10.1186/1478-7954-11-7.ArticlePubMedPubMed CentralGoogle Scholar76.Canadian diabetes association. Journal of Diabetes EBM. Can J diabetes. 2003;27:81–2. doi:10.1111/j.1753-0407.2009.00008.x.Google Scholar77.Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32:S1–201. doi:10.1503/cmaj.080554.Google Scholar78.American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;. doi:10.2337/dc10-S011.Google Scholar79.Howard JA, Sommers R, Gould ON, Mancuso M. Effectiveness of an HbA1c tracking tool on primary care management of diabetes mellitus: glycaemic control, clinical practice and usability. Inform Prim Care. 2009;17:41–6.PubMedGoogle Scholar80.Schienkiewitz A, Schulze M, Hoffmann K, et al. Body mass index history and risk of type 2 diabetes: results from the European prospective investigation into cancer and nutrition (epic)–potsdam study. Am J Clin Nutr. 2006;84:427–33.CASPubMedGoogle Scholar81.Imran SA, Rabasa-Lhoret R, Ross S. Targets for glycemic control. Can J Diabetes. 2013;37:S31–4. doi:10.1016/j.jcjd.2013.01.016.ArticlePubMedGoogle Scholar82.Florkowski C. HbA1c as a diagnostic test for diabetes mellitus. Clin Biochem Rev. 2013;34:75–83.PubMedPubMed CentralGoogle Scholar83.Bazerbachi F, Nazarian S, Alraiyes AH, Alraies MC. Q: is hemoglobin A1c an accurate measure of glycemic control in all diabetic patients? Cleve Clin J Med. 2014;81:146–9. doi:10.3949/ccjm.81a.13147.ArticlePubMedGoogle Scholar84.Goldenberg R, Punthakee Z. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2013;37:8–11. doi:10.1016/j.jcjd.2013.01.011.ArticleGoogle Scholar85.American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:67–74. doi:10.2337/dc13-S067.ArticleGoogle ScholarDownload referencesAuthors’ contributionsVT contributed to the manuscript by creating the databases, analyzing and interpreting the results. MB contributed to the acquisition of the data and helped analyzing and interpreting the results. EL helped with the creation of databases and the interpretation of the results. LB helped with the interpretation of the results. SH helped with the interpretation of the results. BG contributed to the acquisition of the data and interpretation of the results. MM helped with acquisition of the data and the interpretation of the results. VT wrote the first version of the article and MB, EL, LB, MA, SH, BG and MM critically revised the manuscript. All authors approved the final version of the article.AcknowledgementsThe authors would like to thank Michel Arsenault from the New Brunswick Health Council for his previous experience and expertise with these datasets and for facilitating access to the data, and to members of the New Brunswick Department of Health who supported the extraction and transfer of the data.Competing interestsThe authors declare that they have no competing interests.Availability of data and materialThe population-level data used for this study are readily available through open access from Statistics Canada. The individual-level data analyzed remain the intellectual property of the New Brunswick Department of Health. Through a data sharing agreement, the authors are licensed users of the data, and under the licensing agreement are not permitted to share or distribute the data. Researchers wishing to access those data may contact the Maritime Strategy for Patient Oriented Research Support Unit to obtain more information on how to do so: Maritime SPOR SUPPORT Unit.Ethics approval and consent to participateThe databases used for this study were completely anonymized. The study was approved by the Institutional Review Board of the Centre hospitalier universitaire de l’Université de Sherbrooke.FundingVT was funded to do this work through scholarships from the Canadian Institutes of Health Research (CIHR), Diabète Québec, the Centre de Recherche Médicale de l’ Université de Sherbrooke (CRMUS) and the Maritime SPOR support unit (MSSU) which is funded through the CIHR and the New Brunswick Health Research Foundation. EL was also funded through CRMUS and MSSU.Author informationAffiliationsFaculty of Medicine and Health Sciences, Université de Sherbrooke, 2500 boul. de l’Université, Sherbrooke, QC, J1K 2R1, CanadaVéronique Thibault, Mathieu Bélanger, Emilie LeBlanc & Lise BabinCentre de formation médicale du Nouveau-Brunswick, 100 Des Aboiteaux St, Moncton, NB, E1A 7R1, CanadaVéronique Thibault, Mathieu Bélanger, Emilie LeBlanc & Lise BabinVitalité Health Network, 275 Main Street Suite 600, Bathurst, NB, E2A 1A9, CanadaMathieu Bélanger & Lise BabinNew Brunswick Department of Health, 520 King Street, Fredericton, NB, E3B 6G3, CanadaStuart Halpine & Beverly GreeneNew Brunswick Health Council, 100 des Aboiteaux Street, Suite 2200, Moncton, NB, E1A 7R1, CanadaMichelina Mancuso100 rue des Aboiteaux, Pavillon J.-Raymond Frenette, Moncton, NB, E1A 3E9, CanadaMathieu BélangerCorresponding authorCorrespondence to Mathieu Bélanger.Rights and permissionsOpen Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (Creative Commons - Attribution 4.0 International - CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (Creative Commons - CC0 1.0 Universal) applies to the data made available in this article, unless otherwise stated.Reprints and PermissionsAbout this articleVerify currency and authenticity via CrossMarkCite this articleThibault, V., Bélanger, M., LeBlanc, E. et al. Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysis. Diabetol Metab Syndr 8, 71 (2016). Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysisDownload citationReceived01 August 2016Accepted28 October 2016Published09 November 2016DOIFactors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysisShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkProvided by the Springer Nature SharedIt content-sharing initiativeKeywordsDiabetes mellitusType 2 diabetesEpidemiologyPrevalenceTrendsFactorsDiabetology & Metabolic SyndromeISSN: 1758-5996Contact usSubmission enquiries: Access here and click Contact UsGeneral enquiries: [email protected] more on our blogsReceive BMC newslettersManage article alertsLanguage editing for authorsScientific editing for authorsPoliciesAccessibilityPress centerSupport and ContactLeave feedbackCareersFollow BMCBMC Twitter pageBMC Facebook pageBMC Weibo pageBy using this website, you agree to our Terms and Conditions, California Privacy Statement, Privacy statement and Cookies policy. Manage cookies/Do not sell my data we use in the preference centre.Springer Nature© 2020 BioMed Central Ltd unless otherwise stated. Part of Springer Nature.